| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ernexa Therapeutics Inc. (ERNA) has 0 insiders with recent SEC Form 4 filings, including 20 buys and 0 sells. ERNA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 19, 2015 | Mitgang Steve | Director | Buy | 10,000 | $0.26 | $2,587.20 | +86.2% | |
| Jun 19, 2015 | Yanover Paul | Director | Buy | 40,000 | $0.25 | $9,964.30 | +19.2% | |
| Jun 10, 2015 | Berg Jeffrey Alan | Director, 10% Owner | Buy | 65,000 | $0.27 | $17,697.00 | - | |
| May 28, 2015 | Berg Jeffrey Alan | Director, 10% Owner | Buy | 10,000 | $0.31 | $3,076.00 | - | |
| May 21, 2015 | Krishnan Ram | CEO | Buy | 80,000 | $0.35 | $28,104.00 | New | |
| May 21, 2015 | Wolff Allen | CFO | Buy | 65,500 | $0.36 | $23,580.00 | New | |
| May 15, 2015 | Mitgang Steve | Director | Buy | 5,000 | $0.42 | $2,100.00 | New |